Avantra Biosciences Raises $7M, Plans 2011 Cardiovascular Panel Launch
August 24, 2010
Avantra Biosciences Raises $7M, Plans 2011 Cardiovascular Panel Launch
Avantra was founded last year by Courtagen Capital Group to commercialize the assets of Decision Biomarkers, a protein biomarker technology firm that shuttered its business and filed for Chapter 7 bankruptcy in December 2009.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- People In The News
July 1, 2011 / GenomeWeb Daily News - Avantra to Close on $7M Funding Round; Plans to Roll Out Biomarker-Detection Platform in Early 2011
July 23, 2010 / ProteoMonitor - Agilent Restructures, Laying off 450; Q2 Revenues Flat
May 15, 2013 / GenomeWeb Daily News - TCGA Analysis Uncovers Four Molecular Subtypes for Endometrial Cancer
May 1, 2013 / GenomeWeb Daily News - Roche's Peptide Array, Sequence Capture Programs Unaffected by Planned Restructuring
April 30, 2013 / BioArray News